Lauven P M, Schwilden H, Stoeckel H
Institut für Anästhesiologie, Rheinischen Friedrich-Wilhelms-Universität, Bonn, Federal Republic of Germany.
Eur J Clin Pharmacol. 1987;33(3):261-5. doi: 10.1007/BF00637559.
Methohexitone was administered to 8 healthy adult volunteers as a microprocessor controlled infusion that generated 3 cycles of linearly increasing plasma levels with an anticipated slope of 0.2 microgram.ml-1.min-1. When a deep unconscious state was obtained, as indicated by burst suppression in the EEG, the infusion was stopped and then restarted when the volunteer was fully orientated. Frequent venous blood samples were obtained during and after the infusions to evaluate the threshold concentration at induced sleep and the return of orientation, at the loss and return of the eye lid reflex and corneal reflex, and the appearance and disappearance of EEG burst suppression patterns. From the first to the third infusion cycle only a slight and insignificant increase in the mean threshold concentrations was observed so the plasma levels were averaged over all three infusion cycles. The concentrations (microgram/ml) found were: asleep 3.39 and orientated 3.35, loss 4.42 and recurrence 4.32 of eye lid reflex, loss 6.51 and recurrence 5.18 of corneal reflex, and appearance 10.7 and disappearance 9.3 of burst suppression. Acute tolerance that would have led to a significant increase in threshold concentration from the first to the last infusion cycle was not demonstrated. If induced sleep and the appearance of EEG burst suppression are considered as clinical endpoints of anaesthesia, the therapeutic window of methohexitone covers a mean venous serum concentration range of 3.4 to 10.7 micrograms/ml.
将甲己炔巴比妥给予8名健康成年志愿者,采用微处理器控制输注,产生3个血浆水平呈线性增加的周期,预期斜率为0.2微克·毫升⁻¹·分钟⁻¹。当脑电图显示出现爆发抑制表明达到深度无意识状态时,停止输注,当志愿者完全清醒时再重新开始输注。在输注期间和之后采集频繁的静脉血样,以评估诱导睡眠时的阈浓度以及意识恢复情况、眼睑反射和角膜反射消失及恢复时的情况,以及脑电图爆发抑制模式的出现和消失。从第一个输注周期到第三个输注周期,仅观察到平均阈浓度有轻微且无显著意义的增加,因此将所有三个输注周期的血浆水平进行平均。所测得的浓度(微克/毫升)如下:入睡时为3.39,清醒时为3.35;眼睑反射消失时为4.42,恢复时为4.32;角膜反射消失时为6.51,恢复时为5.18;爆发抑制出现时为10.7,消失时为9.3。未证明存在急性耐受性,即未出现从第一个输注周期到最后一个输注周期阈浓度显著增加的情况。如果将诱导睡眠和脑电图爆发抑制的出现视为麻醉的临床终点,甲己炔巴比妥的治疗窗涵盖的平均静脉血清浓度范围为3.4至10.7微克/毫升。